We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Expert Roundtable: Leaps in Innovation in Cancer Immunology

In this roundtable, four leading cancer immunology researchers have come together to discuss challenges in cancer therapy development.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Recent progress made in cancer immunology, as well as future innovations
The ability to harness the immune system is powerful in combating tumors
How single-cell functional proteomics provides unprecedented amounts of data and insight into tumor–immune interactions
A Deeper Look

More about this

The Future of Cancer Immunology

Understanding the complexities and interactions within the tumor microenvironment is critical in the development of effective and persistent therapies.

Cancer treatments look drastically different today than they did 20 years ago. This discussion details recent progress made in cancer immunology, as well as future innovations.

We thank Lisa Butterfield, PhD, Naval Daver, MD, James Heath, PhD, and Taha Merghoub, PhD, for their keen insights and participation.

Get the